Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/2025-522101-37-00
2025-522101-37-00RecruitingPhase 1

First-in-Human Study of RO7812653

F. Hoffmann-La Roche AG1 site in 1 country12 target enrollmentStarted: December 2, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
12
Locations
1
Study OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 65+ years (18-64 Years, 65+ Years)
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Trial Information System - TISL

Scientific

F. Hoffmann-La Roche AG

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
ONO-7913 Phase I study (ONO-7913)
jRCT2080225170ONO PHARMACEUTICAL CO., LTD.12
Completed
Phase 1
ONO-7912 Phase I Study (ONO-7912-01)
jRCT2080225264ONO PHARMACEUTICAL CO., LTD.12
Unknown
Phase 1
A Phase I Single-Dose Study of RO7046015 in Healthy Japanese Men
jRCT2080223775CHUGAI PHARMACEUTICAL CO., LTD.24
Unknown
Phase 1
A Phase I Single-Dose Study of RO7046015 in Healthy Japanese Me
JPRN-jRCT2080223775CHUGAI PHARMACEUTICAL CO., LTD.24
Completed
Phase 1
ONO-4578 Phase 1 Study (ONO-4578-01)
jRCT2080223441ONO PHARMACEUTICAL CO.,LTD.183